MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs, including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and… - View it on GitHub